A common and crippling consequence of diabetes, diabetic neuropathy is defined by nerve damage brought on by persistent hyperglycemia. The illness is caused by a complicated interaction between inflammation, oxidative stress, and abnormalities in metabolism. There are few therapeutic options available today, and most of them concentrate on managing symptoms rather than treating the underlying causes of nerve injury. Because of its strong antioxidant properties and capacity to regulate important biological pathways involved in nerve regeneration and protection, vitamin E has drawn interest as a possible therapeutic benefit for diabetic neuropathy and diabetes. By scavenging free radicals, vitamin E, especially as alpha-tocopherol, is essential for shielding cells from oxidative damage. The antioxidant effect of vit. E is essential for managing diabetes because it lowers the risk of neuropathy by increasing anti-inflammatory processes, improving endothelial function, and preventing the generation of advanced glycation end products all of which improve the body’s general health. As of right now, studies have indicated that vit. E may effectively decrease diabetic neuropathy symptoms including pain and sensory loss as well as prevent the advancement of nerve damage. This research includes preclinical and clinical investigations. Mixed findings have been obtained, nevertheless, due to differences in the research design, patient groups, dose, and types of vitamin E employed. In order to close these knowledge gaps, more study is required. This research should concentrate on understanding the connections between Vitamin E and other medicinal drugs, as well as on precisely determining the mechanisms by which it exerts its neuroprotective benefits and optimizes dose and delivery. Extensive, multi-center clinical trials with a wide range of participants are necessary to verify the safety and effectiveness of vitamin E in diabetic neuropathy and investigate its potential in combination treatments.